
INTRODUCTION: ECT remains one of the most effective treatments for severe depression, including psychotic and treatment-resistant presentations and high-acuity cases requiring rapid response. This review examines ECT as a parameter-sensitive neuromodulation procedure rather than a fixed convulsive treatment. AREAS COVERED: We review historical development, clinical efficacy, safety, relapse prevention, and mechanistic models involving seizure induction, electric-field effects, inhibitory plasticity, neurochemical and neuroendocrine signaling, network change, and postictal brain states. The literature was identified through searches of PubMed/MEDLINE, Web of Science, Scopus, IEEE Xplore, and Google Scholar from database inception to June 2026, supplemented by reference-list screening, with evidence evaluated according to study design, clinical relevance, and technological maturity. Established components of contemporary ECT practice are distinguished from near-term optimization strategies and experimental technologies. EXPERT OPINION: Precision ECT should be regarded as an emerging framework rather than an established standard of care. Patient-specific electric-field modeling, biomarker-guided dosing, amplitude optimization, and adaptive stimulation are promising strategies for improving the therapeutic index, but require prospective validation against optimized standard ECT using clinical, cognitive, and patient-reported outcomes.
INTRODUCTION Artificial intelligence (AI) is increasingly being used to support glaucoma detection and monitoring, with rapid advances in deep learning, multimodal imaging, and longitudinal prediction. This review evaluates the evidence supporting these developments and identifies barriers to clinical translation. AREAS COVERED A systematic search of PubMed, IEEE Xplore, ScienceDirect, and SpringerLink was conducted following PRISMA guidelines, with the protocol registered in PROSPERO (CRD420261450819). Of 3,758 records identified, 63 eligible peer-reviewed studies published between 2015 and 2026 were included. The review examined AI techniques, imaging modalities, datasets, diagnostic and predictive performance, validation strategies, and reported limitations in Glaucoma care. Most studies used deep learning applied to fundus photography, optical coherence tomography (OCT), OCT angiography, visual fields, or multimodal data. Many models achieved an area under the ROC curve of approximately 0.95. EXPERT OPINION AI has substantial potential to improve glaucoma detection and monitoring, but high reported accuracy alone does not establish clinical readiness. Prospective multicenter validation using diverse populations, explainable and reproducible models, standardized evaluation, and integration into clinical workflows are essential before widespread implementation.